Pharmaceuticals

Stablecoin Development

Stablecoin Development released FY2026 Q1 earnings on May 15 (EST), actual revenue USD 25.14 M (forecast USD 3.6 M), actual EPS USD 3.33

Stablecoin Development Company Reports Q1 2026 Earnings, Net Income Hits $552M

Stablecoin Development Company Secures $134 Million Investment and Acquires 2.06 Billion SKY Tokens

Tether Participates in Stablecoin Development Corporation's $134 Million Funding Round

Stablecoin Development released FY2025 Q4 earnings on March 19 (EST), actual revenue USD -521K (forecast USD 3M), actual EPS USD -1.3379 (forecast USD -1)

Stablecoin Development released FY2024 Q4 earnings on March 19 (EST), actual revenue USD 0 (forecast USD 2.5 M), actual EPS USD -0.5616

Stablecoin Development released FY2025 earnings on March 19 (EST), actual revenue USD 0 (forecast USD 12 M), actual EPS USD -3.8042 (forecast USD -4.3)

Stablecoin Development released FY2024 Annual Earnings on March 19 (EST), actual revenue USD 0 (forecast USD 9.9 M), actual EPS USD -12.6774

Stablecoin Development released FY2025 Q3 earnings on November 7 (EST), actual revenue USD 521K (forecast USD 3M), actual EPS USD -1.1159 (forecast USD -1.05)

Stablecoin Development released FY2024 Q3 earnings on November 7 (EST), actual revenue USD 0 (forecast USD 2.625 M), actual EPS USD -9.6207

Stablecoin Development released FY2024 9 Months Earnings on November 7, 2025 (EST) with actual revenue of USD 0 and EPS of USD -166.2322

Stablecoin Development released FY2025 9 Months earnings on November 7 (EST), actual revenue USD 521K, actual EPS USD 4.445

Stablecoin Development Corporation released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 0 (forecast USD 3 M), actual EPS USD -1.6639 (forecast USD -1.05)

Stablecoin Development released FY2024 Q2 earnings on August 14 (EST), actual revenue USD 0 (forecast USD 3.155 M), actual EPS USD -6.8614

Stablecoin Development released FY2024 Semi-Annual earnings on August 14, 2025 (EST) with actual revenue of USD 0 and EPS of USD -27.844

Stablecoin Development released FY2025 Semi-Annual earnings on August 14, 2025 (EST), with actual revenue of USD 0 and EPS of USD 5.1653

Stablecoin Development released FY2024 Q1 earnings on May 15 (EST), actual revenue USD 0 (forecast USD 3.28 M), actual EPS USD -149.75

Stablecoin Development Corporation released FY2025 Q1 earnings on May 15 (EST), actual revenue USD 0 (forecast USD 3M), actual EPS USD 7.2249 (forecast USD -1.2)

Stablecoin Development released FY2023 Q4 earnings on April 2, 2025 (EST), actual revenue USD 2.101 M (forecast USD 3.4 M), actual EPS USD -232.6507

STABLECOIN DEVELOPMENT CORPORATION released FY2023 Annual Earnings on April 2, 2025 (EST): Actual Revenue USD 10.46 M (Forecast USD 14.4 M), Actual EPS USD -695.7083

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

Akanda

Agape ATP

Netcapital

NewGenIvf

Tradr 2X Long QBTS Daily ETF

Co-Diagnostics

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Tradr 2X Long RGTI Daily ETF

Defiance Daily Target 2X Long RGTI ETF

SDEV

GELS

PHGE

In Wednesday's after-market session, Liminatus Pharma (LIMN) surged 24.1% to $0.23, while BiomX (PHGE) rose 12.33% to $0.67. Jupiter Neurosciences (JUNS) and Stablecoin Development (SDEV) also saw gains of 12.19% and 11.18%, respectively. Conversely, HCW Biologics (HCWB) fell 15.6% to $2.05, and MetaVia (MTVA) dropped 9.0% to $2.63. Other notable losers included INVO Fertility (IVF) and Gelteq (GELS) with declines of 7.74% and 7.72%.

benzinga_article

Gelteq

BiomX

INVO Fertility

Jupiter Neurosciences

Liminatus Pharma

HCW Biologics

MetaVia

First Trust NYSE Arca Biotech Index Fd

iShares US Pharma

iShares Global Healthcare

ALPS Medical Breakthrough

VG Health

Health Care Select Sector SPDR

iShares Biotechnology ETF

Invesco Nasdaq Biotechnology ETF

SPDR S&P Health Equip

SPDR S&P Biotech

iShares US Medical Devices

Invesco Biotechnology & Genome ETF

iShares US Healthcare Providers

SPDR S&P Health

VanEck Biotech ETF

Direxion S&P Biotech Bull 3X

Alps

Longeveron

Silexion Therapeutics

Nanobiotix SA

LIMINATUS PHARMA INC C/WTS 30/04/2030 (TO PUR COM)

ALPS GROUP INC C/WTS (TO PUR ORD)

SILEXION THERAPEUTICS CORP C/WTS EXP 15/08/2029 (TO PUR COM)

12 Health Care Stocks Moving In Wednesday's After-Market Session

Earnings Watch

Stablecoin Development | 8-K: FY2026 Q1 Revenue: USD 2.5 M

Stablecoin Development | 10-Q: FY2026 Q1 Revenue: USD 25.14 M

COIN

GLXY

CRCL

BSOL

GSOL

BLOK

BLCN

Sky has launched two major initiatives to enhance its governance and institutionalization strategy, following a 25% increase in its Total Value Locked (TVL). The protocol is simplifying its treasury management by shifting from manual governance voting to fixed rule constraints, capping operating expenditures at 20%. Additionally, Sky is developing Laniakea, an institutional-grade on-chain capital allocation infrastructure, to tap into the $300 billion idle stablecoin market. This new framework aims to standardize smart contracts, risk assessment, data systems, and legal compliance, positioning Sky as a network platform for capital agents rather than just a lender.

- Sky, an established DeFi protocol, has seen a 25% increase in total value locked (TVL) while launching initiatives to streamline governance and attract institutional investment.  
- It is restructuring its treasury management system to reduce governance risks and enhance predictability, while also introducing Laniakea, an infrastructure aimed at capturing idle stablecoin liquidity.  
- This shift positions Sky to transition from a single protocol to an institutional-grade operating system, facilitating increased access for institutional assets, although it also introduces risks related to governance and technical complexity.

CoinLive

Coinbase

Galaxy Digital

Circle

Proshares Big Data Refiners ETF

iShares US Digital Infrastructure and Real Estate ETF

Bitwise Solana Staking ETF

T-REX 2X Inverse CRCL Daily Target ETF

Global X Data Center & Dgtl Infrs ETF

Grayscale Solana Staking ETF

Leverage Shares 2X Long CRCL Daily ETF

Amplify Transform Data Sharing ETF

ProShares Ultra CRCL ETF

Siren ETF Trust Siren Nasdaq NexGen Economy ETF

Grove Collaborative

S&P Global

GROVE COLLABORATIVE HOLDINGS INC

Sky's Dual Transformation: Governance Upgrade and On-Chain Institutional Infrastructure

Stablecoin Development Corporation recently secured a substantial $134 million investment from R01 Fund LP, Framework Ventures, Tether Investments, S.A. de C.V., and Sky Frontier Foundation. This investment has enabled the acquisition of 2.06 billion SKY tokens by the corporation.

Unusual Whales

Nabors Industries

NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update

Stablecoin Development Corporation (SDEV), backed by Tether, has completed a $134 million private placement to enhance its holdings in SKY tokens. Currently, SDEV holds approximately 2.15 billion SKY tokens, representing about 9.15% of the total supply.

Tether-Backed SDEV Completes $134 Million Private Placement to Boost SKY Holdings

Tether has supported a $134 million funding round for Stablecoin Development Corporation (SDEV), aimed at enhancing stablecoin infrastructure and the SKY ecosystem. SDEV, which holds about 2.15 billion SKY tokens, seeks to promote stablecoin applications and DeFi in real-world scenarios. Tether's CEO emphasized that the future growth of stablecoins will rely on improved usability and infrastructure, shifting focus towards everyday payments and practical uses.

Tether supported SDEV's $134 million funding round to develop stablecoin infrastructure and the SKY ecosystem.

RDGT

ANNA

Overview of the US Stock Market The current market shows a clear trend of differentiation, with technology stocks and the biopharmaceutical sector performing particularly well. Stocks with significant gains are mainly concentrated in innovative companies and emerging technology fields, with funds seemingly favoring high-growth stocks. Meanwhile, some traditional industries and small-cap stocks have faced considerable selling pressure, leading to increased overall volatility and a rise in short-term trading activity. The sharp decline of Ridgetech (down 90.50%) in the last hour has attracted widespread attention in the market, with trading volume significantly increasing and investor sentiment becoming tense. The stock's dramatic fluctuations appear to be related to recent financial issues, prompting a rapid withdrawal of funds. Strong stocks: 1. Fundrise Innovation Fund LLC: up 51.09%, with a six-month gain of 270.27%, continuously attracting capital inflows and boosting market sentiment. 2. AleAnna: up 46.65%, reaching a new 60-day high, with active short-term funds and optimistic market outlook. 3. Swarmer: up 44.15%, with increased trading volume indicating strong buying interest. 4. Sol-Gel Tech: up 41.24%, with a six-month gain of 215.83%, as investors are excited about its product line expansion. 5. YD Bio: up 34.67%, with significantly increased trading volume, as the market shows interest in its new drug development progress

Price Alert

Ridgetech

Fundrise Innovation Fund LLC

AleAnna

Swarmer

Sol-Gel Tech

YD Bio

Yimutian

Merlin

Novabay Pharmac

Quantum Biopharma

Southland

Hitek Global Inc.

Jianzhi Edu Tech

Ryde

Erayak Power Solution

ImmunityBio

U.S. Stock Market Movement Update: The U.S. stock market experienced significant volatility, with Ridgetech plummeting 90.50% and Fundrise Innovation Fund soaring 51.09%

Stablecoin Development(SDEV.US)